Colfax Corp (NYSE:CFX) – Investment analysts at Gabelli raised their FY2018 EPS estimates for shares of Colfax in a research report issued to clients and investors on Monday, according to Zacks Investment Research. Gabelli analyst M. Trusz now forecasts that the industrial products company will earn $2.20 per share for the year, up from their prior forecast of $2.10. Gabelli currently has a “Buy” rating on the stock. Gabelli also issued estimates for Colfax’s FY2019 earnings at $2.35 EPS, FY2020 earnings at $2.55 EPS and FY2021 earnings at $2.70 EPS.
Several other equities analysts have also issued reports on CFX. Seaport Global Securities reaffirmed a “buy” rating on shares of Colfax in a report on Wednesday, February 7th. KeyCorp reduced their target price on Colfax from $46.00 to $44.00 and set an “overweight” rating for the company in a report on Wednesday, February 7th. Robert W. Baird reduced their target price on Colfax from $47.00 to $42.00 and set an “outperform” rating for the company in a report on Wednesday, February 7th. Stifel Nicolaus reduced their target price on Colfax from $48.00 to $40.00 and set a “buy” rating for the company in a report on Wednesday, February 7th. Finally, Zacks Investment Research lowered Colfax from a “hold” rating to a “sell” rating in a report on Tuesday, October 24th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $44.40.
Colfax (NYSE CFX) traded down $0.50 during mid-day trading on Tuesday, hitting $32.54. The stock had a trading volume of 122,763 shares, compared to its average volume of 892,039. The company has a market capitalization of $3,977.14, a price-to-earnings ratio of 27.31, a PEG ratio of 1.11 and a beta of 1.17. The company has a current ratio of 1.80, a quick ratio of 1.47 and a debt-to-equity ratio of 0.38. Colfax has a 52 week low of $31.50 and a 52 week high of $43.29.
Colfax (NYSE:CFX) last released its earnings results on Tuesday, February 6th. The industrial products company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.44 by $0.01. The company had revenue of $874.00 million during the quarter, compared to analyst estimates of $894.02 million. Colfax had a return on equity of 6.11% and a net margin of 4.28%. Colfax’s quarterly revenue was up 7.6% on a year-over-year basis. During the same period in the prior year, the company posted $0.46 earnings per share.
Several large investors have recently bought and sold shares of the business. M&T Bank Corp lifted its position in shares of Colfax by 0.7% during the second quarter. M&T Bank Corp now owns 5,510 shares of the industrial products company’s stock worth $216,000 after acquiring an additional 41 shares in the last quarter. The Manufacturers Life Insurance Company lifted its position in shares of Colfax by 7.3% during the second quarter. The Manufacturers Life Insurance Company now owns 3,688 shares of the industrial products company’s stock worth $145,000 after acquiring an additional 251 shares in the last quarter. Eqis Capital Management Inc. lifted its position in shares of Colfax by 11.7% during the third quarter. Eqis Capital Management Inc. now owns 13,531 shares of the industrial products company’s stock worth $563,000 after acquiring an additional 1,415 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in shares of Colfax by 49.0% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 5,264 shares of the industrial products company’s stock worth $209,000 after acquiring an additional 1,731 shares in the last quarter. Finally, Pacer Advisors Inc. lifted its position in shares of Colfax by 11.6% during the third quarter. Pacer Advisors Inc. now owns 17,630 shares of the industrial products company’s stock worth $734,000 after acquiring an additional 1,834 shares in the last quarter. Hedge funds and other institutional investors own 75.82% of the company’s stock.
In other Colfax news, EVP Daniel A. Pryor sold 53,333 shares of the stock in a transaction on Tuesday, December 19th. The stock was sold at an average price of $38.15, for a total transaction of $2,034,653.95. Following the completion of the transaction, the executive vice president now directly owns 93,557 shares of the company’s stock, valued at $3,569,199.55. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP A. Lynne Puckett sold 7,270 shares of the stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $42.01, for a total value of $305,412.70. The disclosure for this sale can be found here. 10.60% of the stock is currently owned by corporate insiders.
ILLEGAL ACTIVITY NOTICE: “Equities Analysts Set Expectations for Colfax Corp’s FY2018 Earnings (NYSE:CFX)” was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another domain, it was stolen and republished in violation of United States and international copyright law. The original version of this story can be accessed at https://www.dispatchtribunal.com/2018/02/13/fy2018-eps-estimates-for-colfax-corp-increased-by-gabelli-cfx.html.
Colfax Corporation is an industrial manufacturing and engineering company. The Company provides air and gas handling, and fabrication technology products and services. The Company’s segments include Air and Gas handling, and Fabrication Technology. The Air and Gas Handling segment supplies a range of gas handling products, including heavy-duty centrifugal and axial fans, rotary heat exchangers, gas compressors, pumps and certain related products, as well as aftermarket services.
Get a free copy of the Zacks research report on Colfax (CFX)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Colfax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colfax and related companies with MarketBeat.com's FREE daily email newsletter.